The global pandemic brought about many changes on how patients are recruited for clinical trials. One of the changes is the use of eConsent, which makes the consent process easy for patients through online platforms or mobile applications.

In any clinical trial, sponsors must ensure participants understand key information, including the trial’s possible risks and benefits. Securing patients’ informed consent has been a challenging process, complicated by complex scientific language and long forms, resulting in reduced compliance and increased trial withdrawals. 

Persuasive digitalization in recent years of clinical trials has eased the burden for patients at multiple points, including during the Informed Consent process. Electronic informed consent or eConsent, refers to the use of electric systems and processes to engage prospective trial participants with interactive media, share relevant information with them, and obtain their informed consent. 

eConsent makes form completion easier for patients, who can give their informed consent either remotely from the comfort of their homes or directly at trial sites. These tools help improve the patient experience while enabling trial sponsors to collect higher-quality data.

Learn more below about how RWS can make devising a superior multilingual eConsent platform easy!